Loading live market data…

Intuitive Surgical, Inc.

NASDAQ:ISRG

$388.97 USD

$9.47 (2.5%)

Volume
4.14M
Average Volume
2.52M
Market Capitalization
$137.76B
P/E Ratio
46.47
Dividend Yield
0.00%
Price Target
$575.00
Year High
$603.88
Year Low
$378.50
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$6.03
Source Headline
Can ISRG Defend Its Leadership as Global Competition Intensifies?

ISRG is countering rising global robotic surgery competition with tiered platforms, AI features and a broad ecosystem focused on value over price.

zacks.com - 2026-07-15 13:05:19

Should You Buy Intuitive Surgical Stock Before Earnings on July 16?

The robotic surgery company has posted earnings beats in its past four quarters. Can it make it five in a row?

fool.com - 2026-07-15 08:47:00

Goldman Sachs Says the Crowd Is Wrong on This Beaten-Down Medical Robotics Giant

Despite Intuitive Surgical's near-term headwinds, one analyst thinks the stock could soar from current levels. The company's ongoing efforts could pay off eventually as it rides the underpenetrated robotic surgery market.

fool.com - 2026-07-15 00:15:00

Here's Exactly Why Intuitive Surgical Stock Is Floundering in 2026

Intuitive Surgical's stock has fallen by more than 25% so far in 2026. The stock is off by more than 30% from its 52-week high.

fool.com - 2026-07-14 16:15:00

Intuitive Surgical Pre-Q2 Analysis: Buy, Hold or Sell the Stock Now?

Intuitive Surgical heads into Q2 earnings with strong procedure momentum, da Vinci 5 adoption and expectations for another earnings beat despite margin pressures.

zacks.com - 2026-07-14 10:56:33

Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H

ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.

zacks.com - 2026-07-14 08:41:07

Buy 5 Large-Cap Stocks With Extensive Robotics Applications for 2H 2026

Buy 5 large-cap robotics stocks, ISRG, TER, CDNS, MCHP and FTV for 2H 2026 supported by AI, automation and expanding robotics applications.

zacks.com - 2026-07-13 09:25:20

Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16

Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value.

247wallst.com - 2026-07-13 08:00:22

Breakfast News: Can Netflix's Ads Fuel a Rebound?

Netflix and banks kick off earnings season, markets start the week shaky, and more

fool.com - 2026-07-13 07:30:00

Intuitive Surgical Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Intuitive Surgical, Inc. (NASDAQ:ISRG) will release its second quarter earnings report after the closing bell on Thursday, July 16.

benzinga.com - 2026-07-13 01:41:32

Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know

Intuitive Surgical, Inc. (ISRG) closed at $406.78 in the latest trading session, marking a -1.16% move from the prior day.

zacks.com - 2026-07-10 18:51:17

ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?

ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.

zacks.com - 2026-07-10 15:11:06

Here Are Thursday's Best Wall Street Analyst Research Calls: Align Technology, American Tower, Caesars Entertainment, Cohu, Five Below, Intuitive Surgical, Salesforce, Toast, and More

Futures are trading mixed after another tough day across Wall Street, with all the major indices crushed early on, before the Nasdaq made a late-afternoon push to wind up just modestly higher at 25,870, up 0.20%.

247wallst.com - 2026-07-09 07:52:34

Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs

Rising use of automation in healthcare is reshaping robotics ETFs as med-tech innovators gain prominence.

zacks.com - 2026-07-08 15:05:24

U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend

Eli Lilly and Intuitive Surgical are top players in their respective corners of the healthcare market. Both companies are highly innovative and boast attractive long-term growth opportunities.

fool.com - 2026-07-07 14:15:00

How Big Is the Appendectomy Opportunity for ISRG's Robotic Expansion?

ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.

zacks.com - 2026-07-07 13:26:01

Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios

Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.

zacks.com - 2026-07-07 10:31:24

Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $432.83, signifying a +1.6% move from its prior day's close.

zacks.com - 2026-07-06 19:01:10

Prediction: Intuitive Surgical Will Be Worth $500 Billion by 2031 -- Here's Why

Intuitive Surgical is a robotic surgery giant and has delivered a track record of growth. The company's revenue has doubled over five years.

fool.com - 2026-07-06 12:05:00

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

zacks.com - 2026-07-06 10:01:14

Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong -- and History Is on Its Side.

Intuitive Surgical is extending the lifetimes of some of its instruments. Revenue surged 23% year over year in the first quarter.

fool.com - 2026-07-03 12:00:00

Why Intuitive Surgical (ISRG) Could Beat Earnings Estimates Again

Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

zacks.com - 2026-07-02 13:11:12

Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?

Abbott Laboratories offers a highly diversified revenue stream across medical devices, diagnostics, nutrition, and generic medicines. Intuitive Surgical maintains a dominant position in robotic-assisted surgery with a high-margin, recurring revenue business model.

fool.com - 2026-07-01 16:08:55

Stryker Vs. Intuitive Surgical: Stryker's Joint-Replacement Moat Over Intuitive's Premium Valuation

Stryker (NYSE:SYK | SYK Price Prediction) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results.

247wallst.com - 2026-07-01 11:14:31

Robotics Then & Now: 2000 to 2026 by the Numbers

In 2000, a “robot” mostly meant a caged arm bolted to a car line, repeating one welded seam. Most could not see, none could leave their cells unsupervised, and a full installation ran into six figures.

etftrends.com - 2026-07-01 07:11:54

Intuitive Surgical's Moat Is Getting Stronger. Is This the Closest Thing to a 'Forever' Stock?

Intuitive Surgical's earnings have climbed progressively over time. The company's flagship robot has a secure position in operating rooms worldwide.

fool.com - 2026-07-01 05:10:00

Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?

Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.

zacks.com - 2026-06-29 14:41:19

Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy.

Over the past decade, Intuitive Surgical's stock has risen more than 400%. The stock has fallen by more than 30% from its all-time high.

fool.com - 2026-06-27 13:15:00

Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $404.27, denoting a +1.14% move from the preceding trading day.

zacks.com - 2026-06-26 18:50:18

The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch

These companies' innovative qualities could help them get ahead of their peers in capitalizing on AI.

fool.com - 2026-06-25 02:00:00

Humanoid Robotics CEO: The First Pure-Play Robot Company Is About to Go Public

Peggy Johnson, a former Microsoft and Magic Leap executive who is now the CEO of Agility Robotics, used a CNBC segment to announce that her company is going public through a SPAC merger with Churchill Capital Corp.

247wallst.com - 2026-06-24 18:07:21

ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?

ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.

zacks.com - 2026-06-24 12:25:33

Is Procedure Growth Broad-Based Enough to Support ISRG's 2026 Outlook?

Intuitive Surgical's ISRG raised its full-year outlook on the first-quarter earnings call, primarily supported by a broadly diversified procedure growth profile. The management increased its 2026 da Vinci procedure growth guidance to 13.5-15.5% from 13-15%, reflecting confidence in sustained adoption trends.

zacks.com - 2026-06-23 11:16:16

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-06-23 10:01:16

This Healthcare Stock Trades at a Richer Valuation Than Nvidia. Could It Also Deliver Bigger Long-Term Returns?

Nvidia makes the computer chips that power artificial intelligence. The chipmaker is doing well right now, but competition is fierce, and technology is changing rapidly.

fool.com - 2026-06-21 10:15:00

1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 50 Years

Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) is positioned for multi-decade compounding because it sits at the center of an aging-world healthcare megatrend with a razor-and-blade business model that compounds quietly whether the broader market is euphoric or fearful.

247wallst.com - 2026-06-18 13:37:02

Bet on 5 Top-Ranked Stocks With Rising P/E for Solid Returns

Rising P/E ratios can signal confidence and momentum. Discover 5 stocks backed by strong earnings growth and upside potential.

zacks.com - 2026-06-18 09:00:50

Intuitive Surgical: A Growth Story You Should Have On Your Radar

Intuitive Surgical stands out from other large cap healthcare companies as a high-growth company and a pure play in very attractive segment of the industry. The seemingly elevated earnings multiple is a cause of concern to many, but it is justified once we account for the overall quality of the business model. International and procedure expansion of ISRG platforms make the highly profitable business model worth considering even at nearly 50 times current earnings.

seekingalpha.com - 2026-06-17 13:46:18

Intuitive Surgical: Priced For Perfection, But The Growth Isn't Done

Intuitive Surgical has become a more attractive opportunity after a 28% stock decline, prompting an upgrade from Hold to Buy. ISRG operates in a high-growth surgical robotics market, which could nearly triple by 2033, supporting long-term bullishness. Despite a premium valuation, ISRG's consistent top and bottom-line growth and management execution justify its price.

seekingalpha.com - 2026-06-17 12:13:58

Billionaire Ken Griffin Sold Amazon and Nvidia but Quietly Loaded Up on This Healthcare Giant

It could be a great move by the billionaire hedge fund manager.

fool.com - 2026-06-16 16:30:00

ISRG's Capital Placement Surge: Demand Strength or Upgrade Cycle Peak?

ISRG placed 431 da Vinci systems in Q1 2026, but rising trade-ins and leasing growth raise questions about whether demand is structural or upgrade-driven.

zacks.com - 2026-06-15 11:36:22

Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

zacks.com - 2026-06-15 10:31:11

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

zacks.com - 2026-06-12 10:00:47

Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $426.61, indicating a +1.91% shift from the previous trading day.

zacks.com - 2026-06-09 18:51:07

Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why

Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

zacks.com - 2026-06-09 13:01:09

Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?

ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.

zacks.com - 2026-06-09 11:11:25

3 Stocks I'm Not Selling No Matter What the Market Does for the Next 20 Years

These companies seem to have what it takes to perform well over decades, through ups and downs. Each has grown huge by executing their plans successfully and adapting to change.

fool.com - 2026-06-08 08:34:00

Can Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance?

Medtronic's Hugo robotic-assisted surgery platform is approved in the U.S. for urologic procedures, and has more applications pending. Intuitive Surgical's da Vinci is the market's flagship platform, and will be difficult to overtake at this point.

fool.com - 2026-06-08 07:21:00

Bargain Hunters: These 3 Growth Stocks Recently Hit New 52-Week Lows

These stocks are down more than 10% this year, and now could be a great time to buy them for the long haul.

fool.com - 2026-06-04 15:00:00

Intuitive Surgical Stock Has Been Hit Hard in 2026. Is It Finally Time to Buy?

The robotic-surgery leader has lost nearly a third of its value since January. Here's what's weighing on the stock.

fool.com - 2026-06-04 14:07:00

Get ISRG Insider Trade Alerts

ISRG Price Target Summary

Last Month

$538.33

6 analysts

Last Quarter

$557.67

9 analysts

Last Year

$605.24

34 analysts

All Time

$474.23

102 analysts

ISRG Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-15 Mizuho Maintain Neutral Neutral
2026-07-13 TD Cowen Maintain Buy Buy
2026-07-13 RBC Capital Maintain Outperform Outperform
2026-07-06 Evercore ISI Group Maintain In Line In Line
2026-05-18 B of A Securities Maintain Buy Buy
2026-04-23 Barclays Maintain Overweight Overweight
2026-04-22 Leerink Partners Maintain Outperform Outperform
2026-04-22 Baird Maintain Outperform Outperform
2026-04-22 Piper Sandler Maintain Overweight Overweight
2026-04-22 BTIG Maintain Buy Buy
2026-04-15 Truist Securities Maintain Buy Buy
2026-04-13 Mizuho Maintain Neutral Neutral
2026-04-10 BTIG Maintain Buy Buy
2026-04-09 Goldman Sachs Maintain Buy Buy
2026-04-06 Evercore ISI Group Maintain In Line In Line
2026-03-17 UBS Maintain Neutral Neutral
2026-03-11 Citigroup Upgrade Neutral Buy
2026-02-24 UBS Maintain Neutral Neutral
2026-01-27 Freedom Capital Markets Upgrade Hold Buy
2026-01-26 Barclays Maintain Overweight Overweight
2026-01-26 Freedom Broker Upgrade Hold Buy
2026-01-23 Piper Sandler Maintain Overweight Overweight
2026-01-23 Bernstein Maintain Outperform Outperform
2026-01-23 Evercore ISI Group Maintain In Line In Line
2026-01-23 Citigroup Maintain Neutral Neutral
2026-01-23 BTIG Maintain Buy Buy
2026-01-09 Bernstein Maintain Outperform Outperform
2026-01-07 BTIG Maintain Buy Buy
2026-01-07 Barclays Maintain Overweight Overweight
2025-12-18 Truist Securities Maintain Buy Buy
2025-12-17 RBC Capital Maintain Outperform Outperform
2025-12-11 Citigroup Downgrade Buy Neutral
2025-10-28 Freedom Broker Maintain Buy Buy
2025-10-23 UBS Maintain Neutral Neutral
2025-10-22 Truist Securities Maintain Buy Buy
2025-10-22 Piper Sandler Maintain Overweight Overweight
2025-10-22 Wells Fargo Maintain Overweight Overweight
2025-10-22 RBC Capital Maintain Outperform Outperform
2025-10-22 BTIG Maintain Buy Buy
2025-10-22 Raymond James Maintain Outperform Outperform
2025-10-15 Truist Securities Maintain Buy Buy
2025-10-13 BTIG Maintain Buy Buy
2025-10-07 Evercore ISI Group Maintain In Line In Line
2025-10-01 BTIG Maintain Buy Buy
2025-08-19 RBC Capital Maintain Outperform Outperform
2025-07-23 BTIG Maintain Buy Buy
2025-07-23 Wells Fargo Maintain Overweight Overweight
2025-07-23 Piper Sandler Maintain Overweight Overweight
2025-07-23 UBS Maintain Neutral Neutral
2025-07-23 Truist Securities Maintain Buy Buy
2025-07-23 RBC Capital Maintain Outperform Outperform
2025-07-08 Evercore ISI Group Maintain In Line In Line
2025-06-09 Deutsche Bank Downgrade Hold Sell
2025-05-22 Citigroup Maintain Buy Buy
2025-04-24 Barclays Maintain Overweight Overweight
2025-04-23 Baird Maintain Outperform Outperform
2025-04-23 Truist Securities Maintain Buy Buy
2025-04-23 RBC Capital Maintain Outperform Outperform
2025-04-23 Piper Sandler Maintain Overweight Overweight
2025-04-23 Evercore ISI Group Maintain In Line In Line
2025-03-18 Baird Maintain Outperform Outperform
2025-03-17 Truist Securities Maintain Buy Buy
2025-01-24 JP Morgan Maintain Overweight Overweight
2025-01-24 Wells Fargo Maintain Overweight Overweight
2025-01-24 Truist Securities Maintain Buy Buy
2025-01-24 Raymond James Maintain Outperform Outperform
2025-01-24 Citigroup Maintain Buy Buy
2025-01-24 Piper Sandler Maintain Overweight Overweight
2025-01-24 Deutsche Bank Maintain Hold Hold
2024-12-18 Truist Securities Maintain Buy Buy
2024-12-11 Wells Fargo Maintain Overweight Overweight
2024-12-11 Citigroup Maintain Buy Buy
2024-12-05 Stifel Maintain Buy Buy
2024-12-02 Morgan Stanley Upgrade Equal Weight Overweight
2024-11-26 BTIG Maintain Buy Buy
2024-11-19 Erste Group Upgrade Hold Buy
2024-10-18 Baird Maintain Outperform Outperform
2024-10-18 Evercore ISI Group Maintain In Line In Line
2024-10-18 RBC Capital Maintain Outperform Outperform
2024-10-18 Stifel Maintain Buy Buy
2024-10-18 BTIG Maintain Buy Buy
2024-10-18 Wells Fargo Maintain Overweight Overweight
2024-10-18 Piper Sandler Maintain Overweight Overweight
2024-10-14 BTIG Maintain Buy Buy
2024-10-14 Raymond James Maintain Outperform Outperform
2024-10-14 Truist Securities Maintain Buy Buy
2024-10-11 JP Morgan Maintain Overweight Overweight
2024-10-08 RBC Capital Maintain Outperform Outperform
2024-10-01 Evercore ISI Group Maintain In Line In Line
2024-08-28 BTIG Maintain Buy Buy
2024-08-22 Citigroup Maintain Buy Buy
2024-08-02 Redburn Atlantic Upgrade Neutral Buy
2024-07-23 Barclays Maintain Overweight Overweight
2024-07-19 Truist Securities Maintain Buy Buy
2024-07-19 Evercore ISI Group Maintain In Line In Line
2024-07-19 Piper Sandler Maintain Overweight Overweight
2024-07-19 JP Morgan Maintain Overweight Overweight
2024-07-19 Morgan Stanley Maintain Equal Weight Equal Weight
2024-07-19 Stifel Maintain Buy Buy
2024-07-19 Baird Maintain Outperform Outperform
2024-07-19 BTIG Maintain Buy Buy
2024-07-18 Barclays Maintain Overweight Overweight
2024-07-16 Truist Securities Maintain Buy Buy
2024-07-15 BTIG Maintain Buy Buy
2024-07-15 Morgan Stanley Maintain Equal Weight Equal Weight
2024-07-10 Citigroup Maintain Buy Buy
2024-07-09 Piper Sandler Maintain Overweight Overweight
2024-07-02 Evercore ISI Group Maintain In Line In Line
2024-04-19 BTIG Maintain Buy Buy
2024-04-19 Piper Sandler Maintain Overweight Overweight
2024-04-19 Jefferies Maintain Hold Hold
2024-04-19 Baird Maintain Outperform Outperform
2024-04-08 Stifel Maintain Buy Buy
2024-04-03 Citigroup Maintain Buy Buy
2024-03-15 Stifel Maintain Buy Buy
2024-01-25 Raymond James Maintain Outperform Outperform
2024-01-25 Mizuho Maintain Neutral Neutral
2024-01-25 Barclays Maintain Overweight Overweight
2024-01-24 Truist Securities Maintain Buy Buy
2024-01-24 Piper Sandler Maintain Overweight Overweight
2024-01-24 RBC Capital Maintain Outperform Outperform
2024-01-24 Stifel Maintain Buy Buy
2024-01-19 Wells Fargo Maintain Overweight Overweight
2024-01-12 RBC Capital Maintain Outperform Outperform
2024-01-03 Raymond James Maintain Outperform Outperform
2023-12-22 Truist Securities Maintain Buy Buy
2023-12-12 Truist Securities Maintain Buy Buy
2023-12-04 Morgan Stanley Maintain Equal Weight Equal Weight
2023-11-17 Stifel Maintain Buy Buy
2023-10-23 Morgan Stanley Maintain Equal Weight Equal Weight
2023-10-20 Piper Sandler Maintain Overweight Overweight
2023-10-20 RBC Capital Maintain Outperform Outperform
2023-10-20 Raymond James Maintain Outperform Outperform
2023-10-20 Citigroup Maintain Buy Buy
2023-10-20 Wells Fargo Maintain Overweight Overweight
2023-08-17 RBC Capital Maintain Outperform Outperform
2023-07-24 Barclays Maintain Overweight Overweight
2023-07-24 Raymond James Maintain Outperform Outperform
2023-07-24 Morgan Stanley Maintain Equal Weight Equal Weight
2023-07-21 RBC Capital Maintain Outperform Outperform
2023-07-21 Piper Sandler Maintain Overweight Overweight
2023-07-21 Wells Fargo Maintain Overweight Overweight
2023-07-21 JP Morgan Maintain Overweight Overweight
2023-07-19 Truist Securities Maintain Buy Buy
2023-07-19 Baird Maintain Outperform Outperform
2023-07-12 RBC Capital Maintain Outperform Outperform
2023-07-11 Citigroup Maintain Buy Buy
2023-06-05 BTIG Maintain Buy Buy
2023-05-31 Bernstein Maintain Outperform Outperform
2023-05-31 Morgan Stanley Maintain Equal Weight Equal Weight
2023-05-18 Truist Securities Maintain Buy Buy
2023-04-24 RBC Capital Maintain Outperform Outperform
2023-04-20 Barclays Maintain Overweight Overweight
2023-04-20 Bernstein Maintain Outperform Outperform
2023-04-19 RBC Capital Maintain Outperform Outperform
2023-04-19 Wells Fargo Maintain Overweight Overweight
2023-04-19 Raymond James Maintain Outperform Outperform
2023-04-19 Piper Sandler Maintain Overweight Overweight
2023-04-19 JP Morgan Maintain Overweight Overweight
2023-04-19 Truist Securities Maintain Buy Buy
2023-04-19 BTIG Maintain Buy Buy
2023-04-19 B of A Securities Maintain Buy Buy
2023-04-19 Morgan Stanley Maintain Equal Weight Equal Weight
2023-04-19 Stifel Maintain Buy Buy
2023-04-19 Citigroup Maintain Buy Buy
2023-04-19 Evercore ISI Group Maintain In Line In Line
2023-04-19 Mizuho Maintain Neutral Neutral
2023-04-19 Deutsche Bank Maintain Hold Hold
2023-04-18 Mizuho Maintain Neutral Neutral
2023-04-17 BTIG Maintain Buy Buy
2023-04-04 Evercore ISI Group Maintain In Line In Line
2023-03-29 UBS Maintain Neutral Neutral
2023-03-23 William Blair Maintain Outperform Outperform
2023-01-26 Raymond James Maintain Outperform Outperform
2023-01-25 Mizuho Maintain Neutral Neutral
2023-01-25 Citigroup Maintain Buy Buy
2023-01-25 Wells Fargo Maintain Overweight Overweight
2023-01-25 Morgan Stanley Maintain Equal Weight Equal Weight
2023-01-25 Truist Securities Maintain Buy Buy
2023-01-25 BTIG Maintain Buy Buy
2023-01-24 Mizuho Maintain Neutral Neutral
2023-01-06 Morgan Stanley Maintain Equal Weight Equal Weight
2022-12-22 Argus Research Maintain Buy Buy
2022-12-20 Truist Securities Maintain Buy Buy
2022-12-12 Wells Fargo Maintain Overweight Overweight
2022-12-05 BTIG Maintain Buy Buy
2022-11-18 JP Morgan Maintain Overweight Overweight
2022-10-20 Deutsche Bank Maintain Hold Hold
2022-10-19 Wells Fargo Maintain Overweight Overweight
2022-10-19 Morgan Stanley Maintain Equal Weight Equal Weight
2022-10-19 Truist Securities Maintain Buy Buy
2022-10-19 Piper Sandler Maintain Overweight Overweight
2022-10-17 Truist Securities Maintain Buy Buy
2022-10-13 Mizuho Maintain Neutral Neutral
2022-10-12 Jefferies Maintain Hold Hold
2022-10-11 Morgan Stanley Maintain Equal Weight Equal Weight
2022-09-09 Stifel Maintain Buy Buy
2022-08-18 Piper Sandler Maintain Overweight Overweight
2022-07-22 Piper Sandler Maintain Overweight Overweight
2022-07-22 Citigroup Maintain Buy Buy
2022-07-22 Truist Securities Maintain Buy Buy
2022-07-22 Deutsche Bank Maintain Hold Hold
2022-07-22 Raymond James Maintain Outperform Outperform
2022-07-22 RBC Capital Maintain Outperform Outperform
2022-07-18 Stifel Maintain Buy Buy
2022-07-18 BTIG Maintain Buy Buy
2022-07-15 Raymond James Maintain Outperform Outperform
2022-07-15 Morgan Stanley Maintain Equal Weight Equal Weight
2022-07-13 Truist Securities Maintain Buy Buy
2022-06-22 Deutsche Bank Maintain Hold Hold
2022-05-17 Citigroup Maintain Buy Buy
2022-04-25 Morgan Stanley Maintain Equal Weight Equal Weight
2022-04-22 Wells Fargo Maintain Overweight Overweight
2022-04-22 Raymond James Maintain Outperform Outperform
2022-04-22 Piper Sandler Maintain Overweight Overweight
2022-04-13 Truist Securities Maintain Buy Buy
2022-04-06 Wolfe Research Maintain Peer Perform Perform
2022-03-25 RBC Capital Maintain Outperform Outperform
2022-02-02 UBS Upgrade Neutral Buy
2022-01-31 Piper Sandler Upgrade Neutral Overweight
2022-01-25 Redburn Partners Downgrade Buy Neutral
2022-01-21 Deutsche Bank Maintain Hold Hold
2022-01-21 Morgan Stanley Maintain Equal Weight Equal Weight
2022-01-21 Citigroup Upgrade Neutral Buy
2022-01-21 Wells Fargo Maintain Overweight Overweight
2022-01-21 Raymond James Maintain Outperform Outperform
2022-01-21 Piper Sandler Maintain Neutral Neutral
2022-01-10 BTIG Upgrade Neutral Buy
2022-01-07 Morgan Stanley Maintain Equal Weight Equal Weight
2021-10-21 Morgan Stanley Maintain Equal Weight Equal Weight
2021-10-20 Wells Fargo Maintain Overweight Overweight
2021-10-05 Morgan Stanley Maintain Equal Weight Equal Weight
2021-10-01 Citigroup Downgrade Buy Neutral
2021-08-26 SVB Leerink Maintain Market Perform Market Perform
2021-07-22 Deutsche Bank Maintain Hold Hold
2021-07-21 Wells Fargo Maintain Overweight Overweight
2021-07-21 Evercore ISI Group Maintain In Line In Line
2021-07-21 SVB Leerink Maintain Market Perform Perform
2021-07-21 Citigroup Maintain Buy Buy
2021-07-21 Morgan Stanley Maintain Equal Weight Equal Weight
2021-07-20 SVB Leerink Maintain Market Perform Market Perform
2021-07-14 Stifel Maintain Buy Buy
2021-06-07 Wells Fargo Maintain Overweight Overweight
2021-06-01 Evercore ISI Group Upgrade Underperform In Line
2021-05-24 Argus Research Maintain Buy Buy
2021-04-21 Citigroup Maintain Buy Buy
2021-04-21 Baird Upgrade Neutral Outperform
2021-04-21 Piper Sandler Maintain Neutral Neutral
2021-04-21 Morgan Stanley Maintain Equal Weight Equal Weight
2021-04-21 SVB Leerink Maintain Market Perform Market Perform
2021-04-21 Deutsche Bank Maintain Hold Hold
2021-04-21 Oppenheimer Upgrade Underperform Perform
2021-04-01 Citigroup Maintain Buy Buy
2021-03-31 Piper Sandler Maintain Neutral Neutral
2021-01-22 Raymond James Maintain Outperform Outperform
2020-12-15 Morgan Stanley Downgrade Overweight Equal Weight
2020-10-16 Morgan Stanley Maintain Overweight Overweight
2020-10-16 Wells Fargo Maintain Overweight Overweight
2020-10-16 SVB Leerink Maintain Market Perform Market Perform
2020-10-12 Raymond James Maintain Outperform Outperform
2020-09-28 Argus Research Maintain Buy Buy
2020-09-11 Wolfe Research Maintain Outperform Outperform
2020-09-08 B of A Securities Downgrade Buy Neutral
2020-09-02 Baird Maintain Neutral Neutral
2020-08-14 SVB Leerink Maintain Market Perform Market Perform
2020-07-22 UBS Maintain Neutral Neutral
2020-07-22 SVB Leerink Maintain Market Perform Market Perform
2020-07-22 Stifel Maintain Buy Buy
2020-07-22 Raymond James Maintain Outperform Outperform
2020-07-22 Wells Fargo Maintain Overweight Overweight
2020-07-22 Deutsche Bank Maintain Hold Hold
2020-07-22 Canaccord Genuity Maintain Buy Buy
2020-07-22 Morgan Stanley Maintain Overweight Overweight
2020-07-15 SVB Leerink Maintain Market Perform Market Perform
2020-06-18 JP Morgan Maintain Overweight Overweight
2020-06-04 Wells Fargo Maintain Overweight Overweight
2020-04-28 Piper Sandler Downgrade Overweight Neutral
2020-04-17 Deutsche Bank Maintain Hold Hold
2020-04-17 Wells Fargo Maintain Overweight Overweight
2020-04-17 Canaccord Genuity Maintain Buy Buy
2020-04-17 UBS Maintain Neutral Neutral
2020-04-17 SVB Leerink Downgrade Outperform Market Perform
2020-04-13 Raymond James Maintain Outperform Outperform
2020-04-09 Evercore ISI Group Downgrade In Line Underperform
2020-04-02 Wells Fargo Maintain Overweight Overweight
2020-04-01 Oppenheimer Downgrade Perform Underperform
2020-03-27 Morgan Stanley Maintain Overweight Overweight
2020-03-24 Stifel Maintain Buy Buy
2020-03-17 JP Morgan Maintain Overweight Overweight
2020-02-13 Goldman Sachs Maintain Buy Buy
2020-01-27 Deutsche Bank Downgrade Buy Hold
2020-01-24 JP Morgan Maintain Overweight Overweight
2020-01-24 Raymond James Maintain Outperform Outperform
2020-01-10 UBS Maintain Neutral Neutral
2020-01-10 Cantor Fitzgerald Maintain Overweight Overweight
2019-12-17 Morgan Stanley Maintain Overweight Overweight
2019-11-29 First Shanghai Maintain Buy Buy
2019-11-21 Oppenheimer Maintain Perform Perform
2019-10-18 UBS Maintain Neutral Neutral
2019-07-19 Canaccord Genuity Maintain Buy Buy
2019-05-14 Citigroup Maintain Buy Buy
2019-04-23 Citigroup Maintain Buy Buy
2019-04-22 Raymond James Maintain Outperform Outperform
2019-04-22 Canaccord Genuity Maintain Buy Buy
2019-04-02 Deutsche Bank Maintain Buy Buy
2019-04-01 Raymond James Maintain Outperform Outperform
2019-01-02 Citigroup Maintain Buy Buy
2018-11-29 Citigroup Maintain Buy Buy
2018-11-28 UBS Maintain Neutral Neutral
2018-10-19 Raymond James Maintain Outperform Outperform
2018-10-19 Canaccord Genuity Upgrade Hold Buy
2018-10-11 Morgan Stanley Maintain Overweight Overweight
2018-10-10 Piper Sandler Upgrade Neutral Overweight
2018-10-10 PiperJaffray Upgrade Neutral Overweight
2018-10-09 Piper Sandler Upgrade Neutral Overweight
2018-10-09 PiperJaffray Upgrade Neutral Overweight
2018-09-12 Wells Fargo Maintain Outperform Outperform
2018-08-02 Citigroup Maintain Buy Buy
2018-07-20 Morgan Stanley Maintain Overweight Overweight
2018-07-20 Stifel Nicolaus Maintain Buy Buy
2018-07-20 Stifel Maintain Buy Buy
2018-07-17 B of A Securities Maintain Buy Buy
2018-07-17 Bank of America Maintain Buy Buy
2018-06-27 Bernstein Maintain Outperform Outperform
2018-06-01 Morgan Stanley Maintain Overweight Overweight
2018-04-18 Morgan Stanley Maintain Overweight Overweight
2018-04-18 Bank of America Maintain Buy Buy
2018-04-18 Stifel Maintain Buy Buy
2018-04-18 B of A Securities Maintain Buy Buy
2018-04-18 Canaccord Genuity Maintain Hold Hold
2018-04-18 Stifel Nicolaus Maintain Buy Buy
2018-02-06 Citigroup Maintain Buy Buy
2018-01-26 Stifel Nicolaus Maintain Buy Buy
2018-01-26 Stifel Maintain Buy Buy
2018-01-26 Canaccord Genuity Maintain Hold Hold
2018-01-26 Barclays Maintain Overweight Overweight
2018-01-26 Morgan Stanley Maintain Overweight Overweight
2018-01-03 Evercore ISI Group Maintain In Line In Line
2017-10-23 Citigroup Maintain Buy Buy
2017-10-20 Morgan Stanley Maintain Overweight Overweight
2017-10-20 Barclays Maintain Overweight Overweight
2017-07-25 Morgan Stanley Maintain Overweight Overweight
2017-06-30 Cantor Fitzgerald Maintain Neutral Neutral
2017-05-16 Goldman Sachs Maintain Buy Buy
2017-01-04 Evercore ISI Group Downgrade Buy Hold
2016-10-13 Wells Fargo Maintain Outperform Outperform
2016-08-26 Raymond James Maintain Outperform Outperform
2016-07-20 Barclays Maintain Overweight Overweight
2016-07-20 Citigroup Maintain Buy Buy
2016-06-02 Goldman Sachs Downgrade Buy Neutral
2016-04-20 B of A Securities Maintain Buy Buy
2016-04-20 Bank of America Maintain Buy Buy
2016-04-01 BTIG Research Downgrade Buy Neutral
2016-04-01 BTIG Downgrade Buy Neutral
2016-01-04 Morgan Stanley Upgrade Equal Weight Overweight
2015-11-12 Citigroup Maintain Buy Buy
2015-07-22 Barclays Maintain Overweight Overweight
2015-07-22 Canaccord Genuity Maintain Buy Buy
2015-07-06 Morgan Stanley Downgrade Equal Weight Underweight
2015-06-25 Barclays Maintain Overweight Overweight
2015-05-12 PiperJaffray Maintain Neutral Neutral
2015-01-05 Jefferies Maintain Buy Buy
2015-01-02 Bank of America Maintain Buy Buy
2015-01-02 B of A Securities Maintain Buy Buy
2014-10-22 Northland Capital Markets Upgrade Underperform Market Perform
2014-10-22 Northland Securities Upgrade Underperform Market Perform
2014-10-22 BTIG Research Upgrade Neutral Buy
2014-10-22 BTIG Upgrade Neutral Buy
2014-10-17 Leerink Swann Upgrade Market Perform Outperform
2014-10-06 Goldman Sachs Upgrade Neutral Buy
2014-09-22 RBC Capital Maintain Sector Perform Perform
2014-07-23 Stifel Upgrade Hold Buy
2014-07-23 JP Morgan Maintain Overweight Overweight
2014-07-23 Stifel Nicolaus Upgrade Hold Buy
2014-07-23 Raymond James Upgrade Market Perform Outperform
2014-07-08 BTIG Research Maintain Neutral Neutral
2014-04-29 Sterne Agee Upgrade Underperform Neutral
2014-04-23 Canaccord Genuity Maintain Hold Hold
2014-04-23 Sterne Agee Maintain Underperform Underperform
2014-04-23 Leerink Swann Maintain Market Perform Market Perform
2014-04-23 SunTrust Robinson Humphrey Maintain Buy Buy
2014-04-23 JP Morgan Maintain Overweight Overweight
2014-04-14 Leerink Swann Maintain Market Perform Market Perform
2014-04-09 Sterne Agee Maintain Underperform Underperform
2014-04-08 Sterne Agee Maintain Underperform Underperform
2014-04-02 JMP Securities Upgrade Market Underperform Market Outperform
2014-04-02 B of A Securities Maintain Buy Buy
2014-04-02 Bank of America Maintain Buy Buy
2014-04-01 JP Morgan Maintain Overweight Overweight
2014-03-04 Cantor Fitzgerald Downgrade Buy Hold
2014-01-21 ISI Group Downgrade Strong Buy Buy
2013-12-05 Jefferies Maintain Buy Buy
2013-11-26 CRT Capital Maintain Sell Sell
2013-11-25 CRT Capital Maintain Sell Sell
2013-10-18 Northland Capital Markets Downgrade Market Perform Underperform
2013-10-18 Northland Downgrade Market Perform Underperform
2013-09-03 First Analysis Downgrade Equal Weight Underweight
2013-07-19 JMP Securities Downgrade Market Perform Market Underperform
2013-07-19 Northland Capital Markets Upgrade Underperform Market Perform
2013-07-19 Northland Securities Upgrade Underperform Market Perform
2013-07-09 Goldman Sachs Downgrade Buy Neutral
2013-07-09 Raymond James Downgrade Outperform Market Perform
2013-07-09 Canaccord Genuity Downgrade Buy Hold
2013-07-09 Ameriprise Financial Downgrade Buy Sell
2013-07-09 JMP Securities Downgrade Market Outperform Market Perform
2013-06-25 First Analysis Maintain Equal Weight Equal Weight
2013-06-18 Wedbush Maintain Outperform Outperform
2013-06-17 Wedbush Maintain Outperform Outperform
2013-03-18 Canaccord Genuity Upgrade Hold Buy
2013-03-05 Northland Maintain Underperform Underperform
2013-03-01 Cantor Fitzgerald Upgrade Hold Buy
2013-02-22 Goldman Sachs Upgrade Neutral Buy
2013-01-23 Cantor Fitzgerald Maintain Hold Hold
2013-01-18 Janney Capital Maintain Buy Buy
2013-01-17 Janney Capital Maintain Buy Buy
2013-01-16 Goldman Sachs Maintain Neutral Neutral
2013-01-14 Lazard Upgrade Neutral Buy
2012-12-04 Cantor Fitzgerald Maintain Hold Hold
2012-11-20 Stifel Nicolaus Maintain Hold Hold
2012-10-31 Barrington Research Upgrade Market Perform Outperform
2012-10-19 B of A Securities Upgrade Neutral Buy
2012-10-19 Bank of America Upgrade Neutral Buy
2012-10-15 JP Morgan Upgrade Neutral Overweight
2012-08-27 Goldman Sachs Maintain Neutral Neutral
2012-07-25 Mizuho Upgrade Neutral Buy
2012-05-30 JP Morgan Maintain Neutral Neutral
2012-04-18 Dougherty & Co. Maintain Buy Buy
2012-04-18 Dougherty Maintain Buy Buy
2012-04-18 JP Morgan Maintain Neutral Neutral
2012-04-18 Goldman Sachs Maintain Neutral Neutral
2012-04-18 Cantor Fitzgerald Maintain Hold Hold
2012-04-10 Dougherty Maintain Buy Buy